A Closer Look at Recent Real-World and Clinical Trial Data in the Management of HR+/HER2- Metastatic Breast Cancer: Expert Perspectives on the Evolving Role of CDK 4/6 Inhibitors

Name: A Closer Look at Recent Real-World and Clinical Trial Data in the Management of HR+/HER2- Metastatic Breast Cancer: Expert Perspectives on the Evolving Role of CDK 4/6 Inhibitors
Brand: National Association of Managed Care Physicians (NAMCP)
Rating: 4.8 (139 reviews)

English

Recorded Courses